Research and Development cannot stand still. Product portfolios are continually being evaluated in the light of market forces and new scientific knowledge. Within Norbrook’s Research & Development headquarters there are over 100 highly qualified and experienced scientists trialling and testing new products. Norbrook’s continuous investment in R&D means that it is well equipped to support the development of new products, and boasts ownership of the largest ‘target species’ research facility in the United Kingdom. Norbrook has specialist experience in drug delivery technologies, including long-acting sterile injectables. We offer expertise in conducting pharmacological, toxicological and stability studies for a wide range of animal species. Clinical trials can also be carried out in a variety of disease models under carefully controlled laboratory and field conditions. All of Norbrook’s research facilities operate to the highest standards of Good Laboratory Practice (GLP). Norbrook’s R&D team are experts in their field. They are dedicated, fully flexible and deliver high quality data packages to our contract research clients. | 
